BioLineRx holds annual shareholder meeting
Bitget2026/09/24 20:07- BioLineRx held its annual shareholder meeting on Sept. 23, 2026.
- Shareholders endorsed the reappointment of Dr. Aharon Schwartz, Dr. Sandra Panem, Dr. Shaoyu Yan as Class III directors through 2029.
- An increase in authorized share capital was adopted, including an amendment to the articles of association; implementation was not detailed.
- Equity-based awards for certain directors were authorized; issuance terms or timing were not specified.
- Kesselman & Kesselman (PwC member firm) was reappointed as independent auditor for the year ending Dec. 31, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
